Vivek Subbiah: Thrilled to share my blog contribution for the AACR Research Catalyst
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn:
“Creating a World Where Precision Oncology is a Reality for All.
On this World Cancer Day, I’m thrilled to share my blog contribution for the American Association for Cancer Research AACR Research Catalyst.
In this piece, I had the privilege of exploring a topic close to my heart: ‘Creating a World Where Precision Oncology is a Reality for All.’
It’s about thinking globally but acting locally to ensure that these advancements are accessible, effective, and impactful for everyone, no matter where they live.
I’m excited to contribute to this important conversation and look forward to hearing your thoughts on the future of cancer care.
Thanks to the fantastic team at AACR for giving me this amazing opportunity to share my thoughts.
Read the full blog here.”
More posts featuring Vivek Subbiah.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023